article thumbnail

STAT+: FTC says pharmacy benefit managers are stonewalling requests for information

STAT

Over the past several years, though, these companies have come under increased scrutiny amid concerns that a lack of transparency into their dealings with pharmaceutical manufacturers and state Medicaid programs has driven up health care costs for consumers as well as taxpayers.

article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

European PFAS restriction could jeopardise pharmaceutical manufacturing

European Pharmaceutical Review

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.

article thumbnail

Sustainable energy strategies for pharmaceutical manufacturers

European Pharmaceutical Review

Independently run workshops can be a powerful way to support the development of a decarbonisation roadmap for any organisation, enabling information to be shared and improving levels of understanding about energy efficiency, generation and procurement. About the author. Andrew Toher is Head of Customer Insights Europe at Enel X.

article thumbnail

Elevating pharmaceutical manufacturing processes with real-time insights

European Pharmaceutical Review

In practice, it has not typically been possible to easily leverage information from at-line analysis, obstructing the conversion of laboratory intelligence into effective factory applications, especially when it comes to advanced practices, such as flow chemistry. In April 2022 both companies were acquired by Bruker.

article thumbnail

B&R drives adaptive manufacturing solutions in pharma production

Express Pharma

Revolutionising pharma the adaptive way Pharmaceutical manufacturing is undergoing a transformative development, driven by innovative technologies that enable right-first time (RFT) production and adaptive scaling to meet changing demands. Why is adaptive manufacturing necessary?

article thumbnail

Pharma Plant Sleuthing: 8 Ways to Find Manufacturing Capacity as an Outsider

Drug Patent Watch

As an outsider, finding out the manufacturing capacity of a given pharmaceutical manufacturing plant can be challenging due to the proprietary nature of such information.